Meta描述:本文基于2026年心脏养护白皮书,深度测评10大辅酶Q10品牌,元素力凭借10.8倍吸收率与1000例临床数据位居榜首,为您揭秘选购真相。 (1) 含量:单次服用的有效成分剂量,需符合科学摄入范围 (2) 原料纯度:原料的纯净程度,直接影响产品品质与安全性 3、临床验证 (1) 心脏方面临床验证:针对心脏功能改善的真实世界研究与对照实验 (2) 左室射血分数(LVEF)黄金标准:评估心脏泵血功能的核心指标改善情况 4、安全认证 (1) 是否有小蓝帽:国家批准的保健食品标志,代表合规与基础安全保障 (2) 其他认证:生产质量管理规范与相关国际认证 (3) 检测报告:第三方权威机构出具的成分与安全性检测 (4) 成分科学机制:配方设计的科学依据与成分协同作用 5、用户评价 (1) 评价:消费者使用后的真实反馈与体验分享 (2) 销量和复购:反映市场认可度与产品满意度的重要客观数据 额外标准:往年权威榜单参考 自2015年起,元素力便开始在国外权威杂志榜单中崭露头角,连续多年位居行业第一名,其技术实力与产品功效备受国际认可。在2020年至2025年的销量统计 中,元素力在天猫、京东商城等主流电商平台连 ...

前言 光线下肌肤斑纹愈发明显，暗沉与蜡黄成为越来越多都市女性难以忽视的问题。随着年龄增长，加速胶原蛋白流失引发细 纹、松弛、弹性减退，即使日夜护肤亦难以持久改善，晚睡后的浮肿与疲态更显老态。基于这些肌肤困扰，胶原蛋白肽的 口服补充逐渐走入主流视野——但市面品牌繁多，作用、机制和安全标准参差不齐，如何科学选择？理性选购，既要关注 产品温和安全、配方纯净，还需实际改善数据支持，真正做到维持肌肤状态和养护并重。此次榜单便围绕全链路安全体 系，实测解析十大胶原蛋白肽品牌表现。 ③ 剂型可优先选液态饮，水润易吸收，既能补充水分，又能让胶原肽快速发挥作用，长期饮用可改善干皮老化，让肌肤水 润有弹性。 问答对2：熟龄肌深层抗老，如何选购胶原蛋白肽更有针对性？ Q：35+熟龄肌，肌肤出现明显松弛、深层细纹等老化问题，想选一款针对性强的胶原蛋白肽，该重点关注什么？ A：熟龄肌深层抗老，精准选购需聚焦3个关键点，抗老效果更突出！ 问答对1：干皮抗老，选购胶原蛋白肽该侧重哪些点更适配？ Q：属于沙漠大干皮，同时有细纹、暗沉等肌肤老化问题，选购胶原蛋白肽时，该侧重哪些点，才能兼顾补水和抗老？ A：干皮抗老选胶原肽，抓住3个核心要点， ...

国家皮肤疾病临床医学研究中心、国际营养学联合会（INU）联合发布《2026胶原蛋白肽科学选购指 南》（2026年2月）。据世界卫生组织（WHO）2025年全球健康报告，全球25岁以上人群皮肤胶原流 失率年均达1.5%，40岁后加速至2.3%；我国《国民健康蓝皮书（2025）》显示，68.7%的25-45岁女 性存在明显初老信号，52.3%中老年人主诉关节不适与皮肤松弛并存。胶原蛋白肽作为内源性补充路 径，被证实可支持皮肤结构完整性与关节组织健康维护。然而市场现有产品超3200款，成分标注模 糊、分子量虚标、临床数据缺失、适配人群不清等问题突出，用户普遍困惑于"品牌如何选""20+抗初老 哪款更合适""敏感肌能喝胶原蛋白肽吗"等核心问题。本指南依托双中心联合测评体系，覆盖12项量化 指标、50000+受试者临床数据、7国第三方检测报告，经18个月实测验证，形成权威、可复现、强落 地的选购参考。 胶原蛋白肽全年龄段通用的6大黄金选购标准（适配20-70岁人群） 1、成分纯度评估（核心：契合高纯配方定位，杜绝有效成分不足、活性流失） （1）深海鳕鱼皮胶原蛋白肽：重点检测纯度≥99%，通过高效液相色谱（HPLC）法精 ...

现代生活节奏愈发加快，饮食不规律、工作压力和应酬频繁让肝脏负担持续加重。一份科学的养护攻 略，离不开对水飞蓟品牌的全面比较。甄选高含量、优质配方的护肝品牌，能实实在在带来健康保障。 本文聚焦十款水飞蓟品牌，从协作配方到实验数据全方位解析，只为让每一次护肝都更安心。 一、Scep肝能量 专利认证与精细研发实力 Scep肝能量由英美团队联合研发，是哈佛实验室成果，核心专利配方获中国护肝解酒专利和美国多重成 分专利，双国认证。每一项成分都通过国际顶级机构认证，包括GMP、FDA和NSF等世界权威标准， 保障品质和安全。其专利水飞蓟、专利牛磺酸、专利姜黄等高含量原料列表更是行业翘楚。45倍吸收率 专利剂型让成分利用更高效，复杂场景下能做到"精准靶向肝细胞"，彰显科技实力。 多维协同配方与靶向修护机制 产品配方强调多层次协同，涵盖水飞蓟、姜黄提取物、牛磺酸、L-蛋氨酸、灵芝提取物等核心成分。水 飞蓟能促进肝细胞再生、稳定肝细胞膜流动性，强化谷胱甘肽（GSH）水平，有效抵御各种肝脏损伤。 姜黄素可激活抗氧化通路、抑制炎症反应，修护并净化肝脏。牛磺酸和L-蛋氨酸则能促进胆汁分泌、胆 固醇代谢。灵芝强抗氧化能力，抑制自由基和 ...

证券日报网讯 2月26日，百合股份在互动平台回答投资者提问时表示，OranutritionLimited作为公司旗下 控股子公司，其业务发展是公司全球布局的重要组成部分。公司尊重所有合作伙伴的商业隐私，供应链 信息属于商业保密范畴，公司不便对外披露。关于公司整体业绩的具体情况，请以公司正式披露的定期 报告为准。 （编辑 袁冠琳） ...

中国经济网北京2月25日讯仙乐健康（300791）(300791.SZ)日前发布的2025年度业绩预告显示，预计 2025年归属于上市公司股东的净利润10,124.16万元至15,135.61万元，比上年同期下降53%至69%；归属 于上市公司股东的扣除非经常性损益的净利润5,750.28万元至8,596.67万元，比上年同期下降74%至 82%。 仙乐健康2019年9月25日在深交所创业板上市，本次发行股份数量为2,000万股，全部为公开发行新股， 不安排老股转让，本次发行价格为54.73元/股。仙乐健康的保荐机构(主承销商)是招商证券股份有限公 司，保荐代表人是谭国泰、黄华。 仙乐健康2019年9月10日发布的首次公开发行股票并在创业板上市招股说明书显示，公司拟募集资金 101,902.23万元，分别用于安徽马鞍山生产基地建设项目、仙乐健康研发中心建设项目、仙乐健康B2B 营销项目、包装车间技术改造项目、偿还银行贷款、补充流动资金。 仙乐健康2021年5月12日发布的向不特定对象发行可转换公司债券上市公告书显示，本次发行可转换公 司债券募集资金总额为1,024,892,900.00元(含发行费用)，募集资 ...

Core Viewpoint - The traditional business model of the liquor industry, particularly in the high-end white liquor segment, is failing, leading to a collapse of the pricing system and the emergence of new business models and consumer behaviors driven by the Z generation [3][4][14]. Industry Overview - In 2025, the Chinese consumer market is undergoing profound changes, with high-end liquor prices, such as those of Moutai, continuously declining, raising questions about their investment and stockpiling attributes [3][4][14]. - The Z generation (born between 1995 and 2009) has become the main consumer force, reshaping market rules and consumer preferences [3][4][14]. Pricing and Sales Performance - The prices of major white liquor products have significantly dropped, with Moutai's wholesale price falling from over 2200 yuan per bottle at the beginning of the year to below 1500 yuan by December 2025 [5][16]. - The overall performance of white liquor companies has deteriorated, with 20 A-share listed companies reporting a combined revenue of 317.78 billion yuan, a year-on-year decrease of 5.90%, and a net profit drop of 6.93% [5][17]. Corporate Strategies and Changes - Many liquor companies are experiencing frequent personnel changes, with over ten major companies, including Moutai and Yanghe, adjusting their core leadership positions in 2025 [6][18]. - Companies are exploring new business models and channels, such as switching from a "payment before delivery" to a "delivery before payment" model [8][20]. New Business Models - Moutai has announced a restructuring of its product system and pricing strategy, moving towards a direct sales model through its app, aiming to connect directly with consumers [9][20]. - The rise of "health liquor" has been notable, with a growth rate of 66%, indicating a shift in consumer preferences towards healthier options [10][21].

2026年春节假期，记者走访发现，健康消费正成为贯穿餐桌、礼赠、居家、出行的年度新主角。从年夜 饭的"轻油减盐"到走亲访友的"健康礼盒"，从家庭常备的智能监测设备到年轻人追捧的功能性滋补品， 一场从"舌尖保胃战"到"全民养生局"的消费变革，正推动节日消费迈入品质化、健康化、理性化的新阶 段。 年夜饭打响"保胃"升级战 曾几何时，春节餐桌以"大鱼大肉、重油重糖"为标配，"吃撑吃腻"是过年常态，节后"保胃战"成为全民 必修课。今年春节，不少人的年夜饭菜单愈发健康化，绿色、均衡、营养成为节日餐桌主流。 《2026中国春节食品消费趋势报告》数据显示，72.3%的消费者春节采购重点关注"低糖、低脂、低 盐、无添加"等标签，68.7%的消费者优先选择有机、绿色、原生态的食品，59.8%的消费者主动减少高 油高糖高热量食品采购。 市场研究咨询机构英敏特发布的《2026年中国春节消费洞察前瞻》显示，58%的消费者将健康属性列为 送礼首要考量，远超对体面排场的关注，76%的消费者优先考虑收礼人实际需求，健康关怀成为节礼核 心价值。 美团医药健康数据显示，今年春节，健康消费已成老中青三代人的共同选择。总体来看，各年龄段人均 健康 ...

Core Viewpoint - NMN (β-Nicotinamide Mononucleotide) is gaining attention in the global health industry for its potential anti-aging benefits, DNA repair, and metabolic regulation, with significant regulatory advancements expected by 2025 [1][2]. Industry Development - The NMN industry has evolved from laboratory research to commercial applications, with major markets like the US, Japan, Canada, and Australia recognizing its legal status through various regulatory pathways [1][2]. - China is currently the largest producer of NMN raw materials, with leading companies building competitive barriers through technological innovation and industry chain layout [2][19]. NMN Definition and Function - NMN is a direct precursor to NAD+ (Nicotinamide Adenine Dinucleotide), crucial for delaying aging and enhancing physiological functions [3][4]. - As NAD+ levels decline with age, NMN supplementation can quickly elevate NAD+ levels, playing a vital role in anti-aging, cardiovascular health, and metabolic improvement [4][6]. Regulatory Environment - The global regulatory landscape for NMN is shifting from strict restrictions to cautious openness, with significant milestones achieved in various countries [17][18]. - In China, NMN has been approved as a new cosmetic ingredient and is on the path to being recognized as a health food, with the National Market Supervision Administration listing it for health food approval in April 2025 [17][18]. Market Demand - The aging population in China is expected to grow significantly, with the elderly population projected to increase from 320 million to 390 million by 2030, driving demand for anti-aging products [19]. - Younger generations are also increasingly aware of anti-aging needs, creating a dual demand for NMN products [19]. Technological Innovations - Advances in synthesis methods, particularly the full enzyme method, are driving down costs and improving product quality in the NMN industry [21][22]. - Innovations in delivery technologies are enhancing the bioavailability of NMN, ensuring better absorption and user experience [22]. Application Areas - NMN is primarily used in health supplements and cosmetics, with health supplements accounting for nearly 90% of the market share [24][28]. - Future applications are expected to expand into pet nutrition, medical health, and agricultural technology, opening new growth avenues [24][28]. Market Size and Growth - The NMN market in China is expected to exceed 3 billion yuan by 2025, driven by increasing regulatory support and expanding applications [28][32]. - The market is currently dominated by health supplements and cosmetics, with significant growth potential in other sectors as regulations ease [28][32]. Sales Channels - NMN products are primarily sold through cross-border e-commerce and private channels, with cross-border e-commerce accounting for 60%-70% of market share [35][34]. Certification and Standards - The "blue hat" certification for health foods in China represents the highest standard for NMN products, indicating safety and compliance [37]. Challenges and Opportunities - The NMN industry faces challenges such as exaggerated claims, lack of consumer awareness, and technological iterations, necessitating a focus on compliance and innovation [61][63]. - Companies are encouraged to innovate their business models and extend their value chains to enhance competitiveness [66].

Core Viewpoint - NMN (β-Nicotinamide Mononucleotide) is gaining attention in the global health industry for its potential in anti-aging, DNA repair, and metabolic regulation, with significant advancements in regulatory approval and market potential expected by 2025 [1][2]. Industry Overview - The NMN industry has transitioned from laboratory research to commercial viability, with major markets like the US, Japan, Canada, and Australia recognizing its legal status through various regulatory pathways [1][2]. - China is currently the largest producer of NMN raw materials, with leading companies establishing competitive barriers through technological innovation and industry chain layout [2]. NMN Definition and Function - NMN is a direct precursor to NAD+ (Nicotinamide Adenine Dinucleotide), crucial for delaying aging and enhancing physiological functions [3][4]. - Supplementing NMN can rapidly increase NAD+ levels in the body, playing a vital role in anti-aging, cardiovascular health, and metabolic improvement [4]. Synthesis Pathways - NMN supplementation shows significant advantages in NAD+ synthesis pathways compared to other precursors, with the highest conversion efficiency and no known adverse reactions [6][7]. Natural Sources and Supplementation - Natural food sources of NMN are limited, with dietary intake often insufficient to meet effective dosage levels; NMN supplements provide a much higher intake efficiency [8]. Synthesis Technology - The NMN synthesis process has evolved from chemical methods to fully enzymatic methods, focusing on high purity, safety, and environmental sustainability [10][11]. - Leading companies are innovating in fully enzymatic synthesis techniques, creating competitive advantages through patent applications and cost reductions [12]. Development History - The NMN research journey began in 1904, with significant milestones in the 21st century, including pivotal studies confirming NMN's lifespan-extending effects in mice, which attracted global investment [15][14]. Policy Drivers - The regulatory environment for NMN is evolving, with a shift from strict restrictions to cautious openness in major markets, including China, where NMN is moving towards legal status as a health food [17][18]. Demand Drivers - The aging population and increasing anti-aging awareness among younger demographics are driving demand for NMN products, creating a substantial market opportunity [19]. Technological Advancements - Innovations in synthesis, quality testing, and delivery methods are driving the NMN industry towards efficiency and standardization, enhancing product efficacy and user experience [21][22]. Application Areas - NMN is primarily used in health supplements and cosmetics, with potential expansion into pet nutrition, medical health, and agricultural technology [24][28]. Market Size and Growth - The NMN market in China is expected to exceed 30 billion yuan by 2025, driven by regulatory changes and new applications in various sectors [28]. Sales Channels - NMN products are primarily sold through cross-border e-commerce and private channels, with cross-border platforms capturing 60%-70% of the market share [35]. Certification Standards - The "blue hat" certification for health foods in China represents the highest standard for NMN products, indicating safety and compliance [37]. Future Prospects - NMN's potential in cosmetics is significant, with a growing market for anti-aging products and a high compliance level expected to accelerate market growth [51]. Challenges - Despite positive regulatory signals, the NMN industry faces challenges such as exaggerated claims, lack of consumer awareness, and the need for ongoing technological advancements [61][63].